Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Climbs on the Emerging Markets Bandwagon
Seeking Alpha
Sunday, November 14, 2010 - 12:46pm
tags:
Merck, emerging markets
J&J's Natrecor Safe With Little Benefit, Pfizer's Inspra Works
Bloomberg
Sunday, November 14, 2010 - 12:45pm
tags:
JNJ, Natrecor, congestive heart failure, Inspra, Pfizer
FDA Concerns Over Human Genome Lupus Drug Dent Share Value
Seeking Alpha
Sunday, November 14, 2010 - 12:42pm
tags:
Human Genome Sciences, lupus, Benlysta
Nektar Announces Two Preclinical Data Presentations at Society for Neuroscience 40th Annual Meeting: Neuroscience 2010
Yahoo/PR NewsWire
Sunday, November 14, 2010 - 12:41pm
tags:
Nektar, NKTR-181, pain management, abuse-resistant painkillers, opiods
Biotech Sector Weekly Rewind
The Street
Saturday, November 13, 2010 - 1:18pm
tags:
biotech
Pipeline Promise
Barron's
Saturday, November 13, 2010 - 1:17pm
tags:
Novartis, pipelines
NovaDel Pharma Reports Recent Events and Financial Results for Third Quarter 2010
Centre Daily Times
Saturday, November 13, 2010 - 1:10pm
tags:
NovaDel, earnings
BioSante Pharmaceuticals Reports Third Quarter 2010 Financial Results
Centre Daily Times
Saturday, November 13, 2010 - 1:09pm
tags:
BioSante, earnings
Pfizer Enters Drug Repositioning Collaboration
Pharmaceutical Insight
Saturday, November 13, 2010 - 1:00pm
tags:
Pfizer, Biovista
Pfizer Will Go Beyond 15% Job-Cut Target From Wyeth Deal
WSJ
Saturday, November 13, 2010 - 12:14pm
tags:
Pfizer
SurModics Disappoints in Q4
Yahoo/Zacks
Saturday, November 13, 2010 - 12:12pm
tags:
SurModics, earnings
‘Tis the Season for Celgene?
CNBC
Saturday, November 13, 2010 - 12:05pm
tags:
Celgene
Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
Yahoo/PR NewsWire
Saturday, November 13, 2010 - 12:04pm
tags:
Halozyme, Lispro, diabetes, insulin
Benlysta: Not Perfect, but Good Enough
Motley Fool
Saturday, November 13, 2010 - 12:02pm
tags:
Benlysta, Human Genome Sciences, lupus
Nutrition 21 Announces Financial Results for 1st Quarter Fiscal Year 2011
Yahoo/MarketWire
Saturday, November 13, 2010 - 12:01pm
tags:
Nutrition 21
Amyris Shares Popped: What You Need to Know
Motley Fool
Saturday, November 13, 2010 - 11:55am
tags:
Amyris
New Lupus Drug Facing Hard Questions
Minyanville
Saturday, November 13, 2010 - 11:54am
tags:
Human Genome Sciences, GSK, Benlysta, lupus
Charles River Misses, Trims Outlook
Yahoo/Zacks
Saturday, November 13, 2010 - 11:52am
tags:
Charles River Laboratories
Otsuka plots $2.8B IPO
Fierce Biotech
Friday, November 12, 2010 - 9:51am
tags:
IPOs, Otsuka
Pozen to receive $25 M milestone payment
Yahoo/AP
Friday, November 12, 2010 - 9:49am
tags:
Pozen, vivmo, milestone payments, arthritis, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.